Valence Labs’ Post

What an honour to be at the launch of the Recursion and Valence Labs new 6,700 sq ft office at King's Cross N1C today. The building includes an onsite cafe, bicycle storage, showers, prayer room and mothers room. In line with Recursion’s commitment to sustainability, the building is rated BREEAM “Excellent” and is linked to a site-wide district heating and cooling network that results in net-zero carbon emissions. I was, as I said, “super-pumped” to meet the CEO Chris Gibson - and Valence Labs President Daniel Cohen as well as their new advisor Michael Bronstein the DeepMind Professor of AI at Oxford. London is Recursion’s first European office and they have hopes and plans to grow strongly here. I was particularly pleased that London & Partners played a big role in their London landing journey, supported by Mayor of London, Sadiq Khan . With 1500 AI businesses, and a thriving expanding health and life science sector, London is the best place to find the talent, ideas and space for new drug and treatment development. Recursion is a clinical stage TechBio company decoding biology to industrialise drug discovery. It had developed the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets. The company was co-founded by Chris Gibson from Salt Lake City Utah - Chris says: "As Recursion continues to lead and define the TechBio industry, it's critical we hire the best possible talent, much of which is located in Europe," "London stood out as an ideal location given its brilliant and interdisciplinary talent across the fields of technology, biology and chemistry. It’s also the epicenter for the rapidly growing TechBio sector in Europe, where leading technology and life science companies like Google and Merck both sit within walking distance of our new Recursion site.” “I look forward to expanding our operations in Europe and hiring many new Recursionauts who will help us advance our mission of decoding biology to radically improve lives.” Recursion uses machine learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry, with the world’s 35th most powerful supercomputer. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — Recursion is uniting technology, biology, chemistry and patient-centric data to advance the future of medicine. Last year they acquired Valence Labs, bringing their expertise to the party too. Thanks to Lydia Volans and the team at Mayor of London for setting this up and for a brilliant briefing. MedCity Angela Kukula The Francis Crick Institute Laura Citron Knowledge Quarter Havas

𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗻𝗲𝘄𝘀 𝗶𝗻 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗯𝗶𝗼𝗹𝗼𝗴𝘆! #EvolutionaryScale has raised a whopping $142 million to develop ESM3, a revolutionary AI model for protein design. This has the potential to transform drug discovery, create new treatments, and even tackle environmental issues! Their technology is poised to usher in a new era of scientific exploration. Want to learn more? Check out the full article! https://lnkd.in/gKZy2n6n #AI #biotech #drugdiscovery #proteinresearch

📣Exciting news!📣 We're thrilled to announce the beta launch of LifeSciAI, Biocompare's new AI Assistant. Designed specifically to help scientists plan experiments, locate the right products for their research, and pinpoint experimental conditions buried in scientific articles, this cutting-edge tool is set to revolutionize the industry. 🚀 With LifeSciAI, scientists can say goodbye to wasted time and hello to more productive research. 🙌 Learn more about this incredible tool and how it can help you streamline your research process. Try it today at biocompare.com and let us know how it saved you time! #LifeSciAI #Biocompare #AIassistant #Science #Research

Seeing the UK's approval of the CRISPR-based therapy Casgevy for treating diseases like sickle-cell and β-thalassaemia is inspiring. While the treatment is expensive today, it represents a significant step forward in healthcare. This breakthrough is a clear indication that we're living in a new era. Coupled with rapid progress in AI, these innovations are reshaping not only science but every aspect of our lives. I'm so excited to be working on bioinformatics, mixing both life science and AI! 🧠 It's important to remember, though, that with such innovation comes the need for ethical consideration, ensuring we progress responsibly without hindering the pace of discovery. https://lnkd.in/eFCkJpwf

AET show was great for Gator Bio. I asked AI to write a short essay about BLI technology. Unveiling the Genuine: Gator BLI Redefines Biolayer Interferometry Gator BLI rises above the rest, claiming the mantle of the world's only genuine biolayer interferometry (BLI) technology. This bold statement finds its roots in the unwavering dedication of Dr. Hong Tan, the visionary who pioneered BLI over two decades ago. A Pioneer's Passion Rekindled: Dr. Tan's journey with BLI began at FortéBio, where he played a pivotal role in bringing this revolutionary technology to life. He witnessed firsthand its immense potential to transform diverse scientific fields, from drug discovery to protein analysis. However, a change in ownership at FortéBio led him to a disheartening realization – BLI's progress had stalled. Gator Bio: Where Innovation Ignites: Driven by a burning passion for BLI's potential and a fervent commitment to scientific advancement, Dr. Tan embarked on a bold new venture: Gator Bio. This company represents a testament to his unwavering dedication to BLI, offering next-generation instruments and advancements that push the boundaries of the technology. Beyond Mere Claims: What Makes Gator BLI Genuine? Gator BLI's claim to being the "only genuine BLI" rests on several key differentiators: Pioneered by the BLI Inventor Himself: Dr. Tan's deep understanding of BLI's core principles permeates every aspect of Gator BLI, from its design to its functionality. Cutting-Edge Advancements: Gator BLI boasts revolutionary features, including enhanced sensitivity, unmatched robustness, and unparalleled versatility compared to its predecessors. Widened Horizons of Discovery: Gator BLI empowers researchers across diverse fields, from unraveling the mysteries of drug-protein interactions to understanding the intricate dance of biomolecules. User-Centric Design: Gator BLI prioritizes intuitive operation and accessibility, making it a valuable tool for scientists of all experience levels. A New Chapter in BLI's Legacy: Gator BLI is more than just an instrument; it's a symbol of Dr. Tan's unwavering dedication to scientific progress and a testament to the transformative power of innovation. It represents a new chapter in the BLI story, one where researchers are empowered with the tools they need to unlock groundbreaking discoveries.

With advancements in AI and a growing recognition of the pivotal role machine learning will play in shaping biotech innovation, Israel is poised to become a strong computational biology ecosystem. Read more about new opportunities in Israeli biotech in this article from AION Labs CEO, Mati Gill. Thanks Mati, for your mentorship, partnership, and never ending inspiration! Thanks for pushing forward the Israeli health tech ecosystem! https://okt.to/qdYOzp #AI #biotech #innovation #IsraeliInnovation

🔬𝗦𝗮𝗽𝗿𝗼𝘁𝗛𝘂𝗯: 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴✨ Proteins play a crucial role in various biological processes, from medical breakthroughs to genetic discoveries, but understanding their complex structure and function remains a challenge in the scientific community. Recent advancements like 𝗔𝗹𝗽𝗵𝗮𝗙𝗼𝗹𝗱𝟯 have revolutionized protein structure prediction. However, challenges in training and deploying deep learning models for proteins hinder non-ML researchers due to complexities like model selection, coding nuances and dataset preprocessing. 𝗦𝗮𝗽𝗿𝗼𝘁𝗛𝘂𝗯 addresses this gap by enabling researchers to create and train models without advanced ML expertise, focusing on protein function prediction. The platform features 𝗦𝗮𝗣𝗿𝗼𝘁, a universal protein language model enhanced with a novel Structure-Aware (SA) representation. This innovation combines amino acid sequences with 3D structural information, significantly improving prediction capabilities. Another key component, 𝗖𝗼𝗹𝗮𝗯𝗦𝗮𝗽𝗿𝗼𝘁, allows seamless fine-tuning and inference of the SaProt model using Google Colaboratory. This integration ensures that even those without extensive computational resources can participate in advanced protein modeling. 𝗣𝗮𝗽𝗲𝗿: https://lnkd.in/giJdfm6K 𝗚𝗶𝘁𝗛𝘂𝗯: https://lnkd.in/gW8vk5Rf #ProteinModeling #MachineLearning #Bioinformatics #SaprotHub #SaProt #ResearchInnovation #ChembioAI #BoltzmannLabs

ML workflows play a pivotal role in the fast-evolving field of drug discovery. 🧪 A crucial step in drug discovery involves predicting compound properties such as Absorption, Distribution, Metabolism, and Excretion (ADME), as well as Potency and Toxicity a key factor in regulatory approval. Estefanía Barreto-Ojeda, PhD, Machine Learning Engineer at Recursion will share the engineered standardized and automated solutions they have developed to train and deploy predictive models weekly to accelerate the drug discovery process. See her full abstract here: https://lnkd.in/gwSRjPjz 🔑 Key Takeaways: ✅ Structured Approach for building and deploying ML models to predict compound properties in a large-scale setting. ✅ Recursion's Data Management & Model Training Strategies leveraging both cloud and supercomputing resources. ✅ Real-world Applications of Machine Learning in optimizing drug discovery and development. #TMLS2024 #MachineLearning #DrugDiscovery #AI #DataScience #RecursionPharma Toronto Machine Learning Society (TMLS)